The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. The company employs 18,000 full-time employees The company went IPO on 2007-06-15. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
How did ULIHF's recent EPS compare to expectations?
The most recent EPS for The United Laboratories International Holdings Limited is $0.06, beating expectations of $0.06.
How did The United Laboratories International Holdings Limited ULIHF's revenue perform in the last quarter?
The United Laboratories International Holdings Limited revenue for the last quarter is $0.06
What is the revenue estimate for The United Laboratories International Holdings Limited?
According to 3 of Wall street analyst, the revenue estimate of The United Laboratories International Holdings Limited range from $6.92B to $6.46B
What's the earning quality score for The United Laboratories International Holdings Limited?
The United Laboratories International Holdings Limited has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does The United Laboratories International Holdings Limited report earnings?
The United Laboratories International Holdings Limited next earnings report is expected in 2026-06-22
What are The United Laboratories International Holdings Limited's expected earnings?
The United Laboratories International Holdings Limited expected earnings is $5.27B, according to wall-street analysts.
Did The United Laboratories International Holdings Limited beat earnings expectations?
The United Laboratories International Holdings Limited recent earnings of $5.69B beat expectations.